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background:  Efforts are being made to reduce the duration of dual antiplatelet therapy (DAPT) to prevent complications (mostly bleeding) 
without increasing stent thrombosis (ST) rates. Data from randomized clinical trials (RCTs) is affected by low power to detect a difference in 
ST rates. We conducted a meta-analysis of all available RCTs to assess the impact of duration of DAPT on clinical outcomes including ST.
methods: A comprehensive literature search using PubMed identified 5 RCTs reporting clinical outcomes with short [≤ 6 mths] vs. long 
duration [≥ 12 mths] of treatment with DAPT. Primary outcome of interest was all-cause mortality. Other clinical endpoints were cardiac 
mortality, myocardial infarction, stroke, stent thrombosis and bleeding complications.
Results: This meta-analysis included 10048 patients (5009 short term; 5039 long-term DAPT). The groups were similar in their baseline 
characteristics and clinical presentation. There was no difference in the incidence of all-cause mortality between 2 groups. Short term 
DAPT use was associated with 35% relative risk reduction (RRR) in any bleeding complication and 44.4% RRR in risk of major bleeding 
events compared to long-term DAPT group (Fig 1a&b). The event rates for ST were very low which renders this meta-analysis severely 
underpowered to detect any difference that may exist (1-sided power 13.6%)
conclusion: Short term DAPT use is associated with lower bleeding complications compared to long term use, with no increase in 
mortality.
 
